MicroPort NeuroScientific Corporation, a leading player in the neurotechnology industry, is headquartered in China (CN) and operates extensively across various global markets. Founded in 2010, the company has rapidly established itself as a pioneer in developing innovative solutions for neurological disorders, focusing on advanced neurostimulation and neuromodulation technologies. MicroPort NeuroScientific's core offerings include cutting-edge devices designed for the treatment of conditions such as epilepsy and chronic pain. What sets them apart is their commitment to integrating advanced engineering with clinical expertise, ensuring that their products are both effective and user-friendly. With a strong market position, the company has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its reach and impact in the neurotechnology sector.
How does MicroPort NeuroScientific Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MicroPort NeuroScientific Corporation's score of 40 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, MicroPort NeuroScientific Corporation reported total carbon emissions of approximately 1,600,000 kg CO2e, with Scope 1 emissions at about 43,760 kg CO2e and Scope 2 emissions at approximately 1,556,240 kg CO2e. This represents a slight decrease from 2023, where total emissions were about 1,665,120 kg CO2e, comprising Scope 1 emissions of around 89,320 kg CO2e and Scope 2 emissions of approximately 1,575,800 kg CO2e. In 2022, the company recorded total emissions of about 1,840,100 kg CO2e, with Scope 1 emissions of approximately 124,140 kg CO2e and Scope 2 emissions at around 1,715,960 kg CO2e. MicroPort NeuroScientific Corporation does not currently have any publicly disclosed reduction targets or climate pledges. The emissions data is cascaded from the parent company, MicroPort NeuroScientific Corporation, indicating a corporate family relationship. The company has not reported any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. Overall, while the company has shown some fluctuations in emissions over the past few years, it has yet to establish formal reduction initiatives or commitments to align with industry standards for climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 124,140 | 00,000 | 00,000 |
| Scope 2 | 1,715,960 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MicroPort NeuroScientific Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

